Profermin®: Prevention of Progression in Alcoholic Liver Disease by Modulating Dysbiotic Microbiota
Profermin®: Prevention of Progression in Alcoholic Liver Disease by Modulating Dysbiotic Microbiota
Active, not recruiting · NCT03863730 · Registry updated 2023-11-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Profermin®: Prevention of Progression in Alcoholic Liver Disease by Modulating Dysbiotic Microbiota | Chemically-Induced Disorders, Digestive System Diseases, Fibrosis, Fibrosis, Liver, Pathologic Processes, Pathological Conditions, Signs and Symptoms, alcohol-induced disorders, alcohol-related disorders, alcoholic liver cirrhosis, alcoholic liver disease, cirrhosis of liver, liver disorder, substance-related disorder | Active, not recruiting | Not applicable | 2023-11-07 | NCT03863730 |
5 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Nordisk Rebalance A/S | 1 |
| Odense Patient Data Explorative Network | 16 |
| Odense University Hospital | 253 |
| Region of Southern Denmark | 22 |
| University of Southern Denmark | 105 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| FLASH - Centre of Liver Research | Odense | Denmark | 1 |
| Odense University Hospital | Odense | Denmark | 97 |